logo
Select company
Select metric
$ -1.17EBITDA per Share
VS
Market
17
Sector
44
Industry
59
History
97
$ 1.2Close
$ 0.85 - $ 6.67 52-Week Range
Ticker Information

Ticker

OTLK

Company Name

OUTLOOK THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OUTLOOK THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OTLK - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -43.25M$ -1.17136.96M
3/31/2025$ 21.26M$ 0.69130.87M
12/31/2024$ -43.61M$ -1.8124.23M
9/30/2024$ -72.09M$ -3.89118.55M
6/30/2024$ -91.36M$ -3.93123.23M
3/31/2024$ -156.86M$ -10.99114.27M
12/31/2023$ -52.51M$ -4.04113.01M
9/30/2023$ -57.38M$ -4.59112.51M
6/30/2023$ -58.02M$ -4.52112.84M
3/31/2023$ -54.1M$ -4.22112.83M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OUTLOOK THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -9.98.
  • Over the past 5 years, OUTLOOK THERAPEUTICS INC's average EBITDAPS has been $ -5.04.
  • The median EBITDAPS for OUTLOOK THERAPEUTICS INC during this period was $ -5.41
  • OUTLOOK THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ 0.69.
  • The lowest EBITDAPS recorded by OUTLOOK THERAPEUTICS INC in the same timeframe $ -10.99

OUTLOOK THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
BTAI : BIOXCEL THERAPEUTICS INC $ -4.41ORMP : ORAMED PHARMACEUTICALS INC $ -0.84CNTB : CONNECT BIOPHARMA HOLDINGS LTD -DTIL : PRECISION BIOSCIENCES INC $ -6.67AVTX : AVALO THERAPEUTICS INC $ -4.42PLUR : PLURI INC $ -3.34COYA : COYA THERAPEUTICS INC $ -1.26VTGN : VISTAGEN THERAPEUTICS INC $ -1.73CLSD : CLEARSIDE BIOMEDICAL INC $ -5.14IGC : IGC PHARMA INC $ -0.07

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for OUTLOOK THERAPEUTICS INC is calculated as follows: EBITDA [ $ -36.2M ] / (Shares WA [ 3.63M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -9.98 ]

OTLK - EBITDA per Share, Last 5 years

$ -10.99

Minimum

Mar 31, 2024

$ 0.69

Maximum

Mar 31, 2025

$ -5.04

Average

$ -5.41

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28